← Leaderboards
Michael L Cleary
Stanford University
$25,231,473
Attributed
$25,231,473
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$25,231,473 · 15
By mechanism
R01$14,365,126 · 5
T32$3,877,095 · 1
R37$3,633,567 · 1
P01$1,536,292 · 3
R24$1,138,211 · 1
P30$481,307 · 2
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- David Feldman$8,560,053
- Helen M Blau$36,149,136
- Irving Lerner Weissman$56,491,773
- Ching-Cheng Chen$919,380
- Upinder Singh$17,854,720
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPathway InteractionsProteinsPathogenesisOncogenicLaboratory MouseLeukemiaBiological ModelsBaseProgramsGeneticMalignant NeoplasmsChromatinChimeric ProteinsGene ExpressionLeukemogenesisAwardTranscription FactorEpigenetic ProcessAcute LeukemiaSignal PathwayResearch PersonnelGenetic TranscriptionAdult
Grant awards (91)
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia$360,034
R01 · FY2023 · CA · contact PI
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia$367,205
R01 · FY2021 · CA · contact PI
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia$367,346
R01 · FY2020 · CA · contact PI
Epigenetic Mechanisms and Targeting in MLL Leukemia$344,911
R01 · FY2020 · CA · contact PI
Cancer Biology Research Program (Project-001)$43,895
P30 · FY2020 · CA · contact PI
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia$356,412
R01 · FY2019 · CA · contact PI
Epigenetic Mechanisms and Targeting in MLL Leukemia$334,409
R01 · FY2019 · CA · contact PI
Cancer Biology Research Program (Project-001)$43,760
P30 · FY2019 · CA · contact PI
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia$366,681
R01 · FY2018 · CA · contact PI
Epigenetic Mechanisms and Targeting in MLL Leukemia$344,872
R01 · FY2018 · CA · contact PI
Cancer Biology Research Program (Project-001)$43,895
P30 · FY2018 · CA · contact PI
Cancer Biology Research Program (Project-001)$11,296
P30 · FY2018 · CA · contact PI
Cancer Biology Research Program (Project-001)$7,796
P30 · FY2018 · CA · contact PI
Epigenetic Mechanisms and Targeting in MLL Leukemia$344,952
R01 · FY2017 · CA · contact PI
Cancer Biology Research Program (Project-001)$32,996
P30 · FY2017 · CA · contact PI
Epigenetic Mechanisms and Targeting in MLL Leukemia$344,745
R01 · FY2016 · CA · contact PI
Role of PGDH in leukemia pathogenesis$334,042
R01 · FY2016 · CA · contact PI
Cancer Biology Research Program (Project-001)$36,781
P30 · FY2016 · CA · contact PI
Role of PGDH in leukemia pathogenesis$333,723
R01 · FY2015 · CA · contact PI
Postdoctoral Training in Tumor Biology$426,513
T32 · FY2014 · CA · contact PI
Role of PGDH in leukemia pathogenesis$323,414
R01 · FY2014 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$296,000
R01 · FY2014 · CA · contact PI
Cancer Biology$123,950
P30 · FY2014 · CA · contact PI
Postdoctoral Training in Tumor Biology$330,553
T32 · FY2013 · CA · contact PI
Role of PGDH in leukemia pathogenesis$313,137
R01 · FY2013 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$286,533
R01 · FY2013 · CA · contact PI
Cancer Biology$75,000
P30 · FY2013 · CA · contact PI
Cancer Biology$14,101
P30 · FY2013 · CA · contact PI
Postdoctoral Training in Tumor Biology$405,446
T32 · FY2012 · CA · contact PI
Role of PGDH in leukemia pathogenesis$332,842
R01 · FY2012 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$304,513
R01 · FY2012 · CA · contact PI
Cancer Biology$15,066
P30 · FY2012 · CA · contact PI
Postdoctoral Training in Tumor Biology$449,236
T32 · FY2011 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$304,221
R01 · FY2011 · CA · contact PI
Cancer Biology$15,417
P30 · FY2011 · CA · contact PI
Postdoctoral Training in Tumor Biology$396,318
T32 · FY2010 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$313,340
R01 · FY2010 · CA · contact PI
Role of PBX Proteins in Hematopoiesis and Growth Control$300,227
R01 · FY2010 · CA · contact PI
Cancer Biology$17,354
P30 · FY2010 · CA · contact PI
Postdoctoral Training in Tumor Biology$390,077
T32 · FY2009 · CA · contact PI
Role of PBX Proteins in Hematopoiesis and Growth Control$300,009
R01 · FY2009 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$295,672
R01 · FY2009 · CA · contact PI
Pathology and Biology of Leukemia Oncogenes$366,118
R01 · FY2008 · CA · contact PI
Postdoctoral Training in Tumor Biology$364,187
T32 · FY2008 · CA · contact PI
Role of PBX Proteins in Hematopoiesis and Growth Control$299,800
R01 · FY2008 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$295,536
R01 · FY2008 · CA · contact PI
Pathology and Biology of Leukemia Oncogenes$373,311
R01 · FY2007 · CA · contact PI
Postdoctoral Training in Tumor Biology$367,103
T32 · FY2007 · CA · contact PI
Role of PBX Proteins in Hematopoiesis and Growth Control$299,598
R01 · FY2007 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$266,696
R01 · FY2007 · CA · contact PI
Inhibitors of MLL-Menin Interaction$196,875
R21 · FY2007 · NS · contact PI
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$562,736
R37 · FY2006 · CA · contact PI
Postdoctoral Training in Tumor Biology$399,424
T32 · FY2006 · CA · contact PI
Pathology and Biology of Leukemia Oncogenes$355,928
R01 · FY2006 · CA · contact PI
Molecular Targeting of MLL and Associated Factors$332,807
R01 · FY2006 · CA · contact PI
Role of PBX Proteins in Hematopoiesis and Growth Control$308,342
R01 · FY2006 · CA · contact PI
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$561,491
R37 · FY2005 · CA
Pathology and Biology of Leukemia Oncogenes$364,438
R01 · FY2005 · CA
Postdoctoral Training in Tumor Biology$348,238
T32 · FY2005 · CA
Role of Pbx Protein in Hematopoiesis and Growth Control$325,721
R01 · FY2005 · CA
Molecular Targeting of MLL and Associated Factors$311,440
R01 · FY2005 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$547,133
R37 · FY2004 · CA
Pathology and Biology of Leukemia Oncogenes$366,152
R01 · FY2004 · CA
Role of Pbx Protein in Hematopoiesis and Growth Control$317,223
R01 · FY2004 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$509,160
R37 · FY2003 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES$340,225
R01 · FY2003 · CA
Role of Pbx Protein in Hematopoiesis and Growth Control$308,970
R01 · FY2003 · CA
MICRO MANIPULATION CORE RESOURCE$285,867
R24 · FY2003 · CA
Hematologic Malignancies$3,000
R13 · FY2003 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$496,511
R37 · FY2002 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES$331,518
R01 · FY2002 · CA
Role of Pbx Protein in Hematopoiesis and Growth Control$300,961
R01 · FY2002 · CA
MICRO MANIPULATION CORE RESOURCE$284,935
R24 · FY2002 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$484,230
R37 · FY2001 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES$323,065
R01 · FY2001 · CA
Role of Pbx Protein in Hematopoiesis and Growth Control$293,181
R01 · FY2001 · CA
MICRO MANIPULATION CORE RESOURCE$284,089
R24 · FY2001 · CA
CONTRIBUTIONS OF THE PBX FAMILY OF HOX COFACTORS TO MAMMALIAN DEVELOPMENT$157,506
P01 · FY2001 · CA
CORE--HYBRIDOMA AND DNA SEQUENCING FACILITY$157,506
P01 · FY2001 · CA
CORE--MOLECULAR AND CYTOGENETIC PATHOLOGY$0
P01 · FY2001 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES$472,306
R37 · FY2000 · CA
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENES$314,856
R01 · FY2000 · CA
MICRO MANIPULATION CORE RESOURCE$283,320
R24 · FY2000 · CA
CORE--MOLECULAR AND CYTOGENETIC PATHOLOGY$221,448
P01 · FY2000 · CA
CONTRIBUTIONS OF THE PBX FAMILY OF HOX COFACTORS TO MAMMALIAN DEVELOPMENT$171,205
P01 · FY2000 · CA
CORE--HYBRIDOMA AND DNA SEQUENCING FACILITY$171,205
P01 · FY2000 · CA
CORE--HYBRIDOMA AND DNA SEQUENCING FACILITY$171,205
P01 · FY2000 · CA
CONTRIBUTIONS OF THE PBX FAMILY OF HOX COFACTORS TO MAMMALIAN DEVELOPMENT$171,205
P01 · FY2000 · CA
CORE--HYBRIDOMA AND DNA SEQUENCING FACILITY$157,506
P01 · FY2000 · CA
CONTRIBUTIONS OF THE PBX FAMILY OF HOX COFACTORS TO MAMMALIAN DEVELOPMENT$157,506
P01 · FY2000 · CA
CORE--MOLECULAR AND CYTOGENETIC PATHOLOGY$0
P01 · FY2000 · CA